Clinical Trials List
2025-09-10 - 2028-06-13
Phase I
Recruiting4
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- 楊涵中 無
- JU-CHUAN HU 無
- Cheng-Kuang Yang 無
- 梅承恩 無
- 林雁婷 無
- Chuan-Shu Chen 無
- 洪晟鈞 無
- Cheng-Che Chen 無
- Shian-Shiang Wang 無
- 張家程 無
- 裘坤元 無
- 賴谷順 無
- 楊哲瑞 無
- 張瓈文 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 鍾秉軒 Division of Hematology & Oncology
- Yuh-Shyan Tsai Division of Hematology & Oncology
- Che-Yuan Hu Division of Hematology & Oncology
- Kuan-Yu Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chao-Hsiang Chang
- 蔡禮賢 Division of Urology
- Wei-Ching Lin
- Chi-Rei Yang Division of Urology
- Hsi-Chin Wu
- Yi-Huei Chang Division of Urology
- Han Chang
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
60 participants
